JAZZ
Jazz Pharmaceuticals plc · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -1.6% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 135 | +4 | 47.42M | $11.41B | +7 | −4 |
| Q1 2026 | 135 | -10 | 49.63M | $8.67B | +4 | −14 |
| Q4 2025 | 144 | +2 | 48.56M | $7.62B | +2 | n/a |
| Q3 2025 | 20 | 0 | 25.68M | $3.38B | +1 | −1 |
| Q2 2025 | 17 | -1 | 21.49M | $2.28B | +1 | −2 |
| Q1 2025 | 15 | 0 | 8.34M | $1.04B | +1 | −1 |
| Q4 2024 | 15 | 0 | 8.56M | $1.05B | +1 | −1 |
| Q3 2024 | 14 | -2 | 7.38M | $822.21M | n/a | −2 |
| Q2 2024 | 16 | n/a | 7.74M | $826.28M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 5.91M | -3.0% | $778.54M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (pasivo) | 5.56M | -4.2% | $732.72M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 3 | JPMorgan Chase ✦ | 3.73M | n/a | $492.18M | 0.0% | n/c | 1 | SEC ↗ ×24 |
| 4 | Capital World Investors ✦ | 2.55M | +0.4% | $336.73M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (pasivo) | 1.87M | -3.5% | $246.19M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (pasivo) | 1.20M | +2.1% | $157.67M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Renaissance Technologies ✦ | 924.87K | +2.7% | $121.90M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 883.95K | +42.1% | $116.50M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 717.62K | n/a | $94.58M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 10 | AQR Capital Management ✦ | 698.94K | -12.1% | $90.96M | 0.1% | ▼ Trim | 6 | SEC ↗ ×4 |
| 11 | Fidelity (FMR) ✦ | 682.14K | +24.6% | $89.91M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 12 | Millennium Management ✦ | 269.11K | -59.3% | $35.47M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 13 | Goldman Sachs Group ✦ | 165.07K | n/a | $21.76M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 14 | Adage Capital Partners ✦ | 153.00K | +13.3% | $20.17M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 129.20K | +8.2% | $17.03M | 0.0% | ▲ Add | 6 | SEC ↗ ×7 |
| 16 | D. E. Shaw & Co. ✦ | 124.37K | +3084.0% | $16.39M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | Gotham Asset Management ✦ | 51.19K | -25.2% | $6.75M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 46.70K | +6.0% | $6.16M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 11.86K | Nuevo | $1.56M | 0.0% | New | 1 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 4.17K | -90.8% | $550,001 | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Point72 Asset Management | $1.56M | 0.0% |
Posición cerrada
| Marshall Wace | $698,057 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 568 tenedores, 63.82M acciones, $11.28B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer, Director · 2.00K acc. · $472,800
Director · 6.00K acc. · $1.38M
Officer · 1.20K acc. · $289,128
Officer · 2.00K acc. · $486,060
Director · 6.00K acc. · $1.50M
Officer · 300 acc. · $75,828
Officer · 18.11K acc. · $4.53M
Officer · 9.26K acc. · $2.33M
Officer · 11.42K acc. · $2.84M
Officer · 18.19K acc. · $4.51M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología